Global Calcium Channel Blocker Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

Segmented by Drug Class;

Dihydropyridine - Amlodipine, Cilnidipine, Felodipine, Isradipine, Nicardipine, Nisoldipine, Nifedipine and Others, Non-Dihydropyridine - Diltiazem and Verapamil.

Segmented by Application;

Angina Pectoris, Hypertension, Pregnancy, Obesity and Others.

Segmented by Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2020 - 2030).
Report ID: Rn693480960 Published Date: April, 2024 Updated Date: May, 2024
Download Free Sample NowDownload Free Sample Now

Introduction

Global Calcium Channel Blocker Market (USD Million), 2020 - 2030

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels
# Global Market (USD Million), 2020 - 2030
2020 89.5
2021 94.2
2022 107.7
2023 110.3
2024 130.9
2025 150.3
2026 179.1
2027 199.3
2028 205.7
2029 229.1
2030 268.9

In the year 2023, the Global Calcium Channel Blocker Market was valued at USD 2,540.61 million. The size of this market is expected to increase to USD 3,099.23 million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of 2.9%.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Drug Class
    2. Market Snapshot, By Application
    3. Market Snapshot, By Region
    4. Market Opportunity Map
  4. Global Calcium Channel Blocker Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Global Calcium Channel Blocker Market Drivers: Impact Analysis
        2. Rising prevalence of Hypertension.
        3. Growth percentage of Obesity
      2. Restraints
        1. Global Calcium Channel Blocker Market Restraints: Impact Analysis
        2. Adverse Effect of Drug
      3. Opportunities
        1. Combination Therapy of CCB Drugs
    2. Regulatory Scenario
    3. Reimbursement Scenario
    4. Mergers & Acquisitions, Collaborations & Partnerships, Agreements
    5. Pipeline Analysis/Technological Advancements
    6. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    7. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bragaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Industry Rivalry
  5. Market Segmentation
    1. Global Calcium Channel Blocker Market, By Drug Class, 2022 - 2032 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2024 and 2030 (%)
      3. Y-o-Y Growth Analysis, 2021 - 2030
      4. Segment Trends
        1. Dihydropyridine
          1. Introduction
          2. Market Share Analysis, 2024 and 2030 (%)
          3. Y-o-Y Growth Analysis, 2021 - 2030
          4. Segment Trends
            1. Amlodipine
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
            2. Cilnidipine
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
            3. Felodipine
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
            4. Isradipine
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
            5. Nicardipine
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
            6. Nisoldipine
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
            7. Nifedipine
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
            8. Others
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        2. Non-Dihydropyridine
          1. Introduction
          2. Market Share Analysis, 2024 and 2030 (%)
          3. Y-o-Y Growth Analysis, 2021 - 2030
          4. Segment Trends
            1. Diltiazem
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
            2. Verapamil
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
    2. Global Calcium Channel Blocker Market, By Application, 2022 - 2032 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2024 and 2030 (%)
      3. Y-o-Y Growth Analysis, 2021 - 2030
      4. Segment Trends
        1. Angina Pectoris
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        2. Hypertension
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        3. Pregnancy
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        4. Obesity
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        5. Others
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
    3. Global Calcium Channel Blocker Market, By Geography, 2022 - 2032 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2024 and 2030 (%)
      3. Y-o-Y Growth Analysis, 2021 - 2030
      4. Regional Trends
        1. North America
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
            1. United States
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
            2. Canada
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
        2. Europe
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
            1. Germany
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
            2. United Kingdom
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
            3. France
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
            4. Italy
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
            5. Spain
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
            6. Rest of Europe
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
        3. Asia Pacific
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
            1. Japan
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
            2. China
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
            3. India
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
            4. Australia & New Zealand
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
            5. South Korea
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
            6. ASEAN (Association of South East Asian Countries)
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
            7. Rest of Asia Pacific
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
        4. Latin America
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
            1. Brazil
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
            2. Mexico
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
            3. Argentina
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
            4. Rest of Latin America
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
        5. Middle East & Africa
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
            1. GCC
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
            2. Israel
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
            3. South Africa
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
            4. Rest of Middle East & Africa
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2030 (USD Million)
  6. Competitive Landscape
    1. Heat Map Analysis
    2. Company Profiles
      1. Pfizer Inc
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      2. AstraZeneca plc
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      3. Bayer Healthcare LLC
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      4. GlaxoSmithKline plc
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      5. Sanofi S.A.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      6. Johnson & Johnson
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      7. Abcam
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      8. AbMole Bioscience
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      9. Clearsynth
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
  7. Analyst Views
  8. Future Outlook of the Market
Download Free Sample NowDownload Free Sample Now

ReAnIn's Most Viewed Titles:

Healthcare In Vitro Diagnostics Caloric test
Global Caloric Test Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

In the year 2023, the Global Caloric Test Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Biotechnology Cancer Biologics
Global Cancer Biologics Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

In the year 2023, the Global Cancer Biologics Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Pharmaceuticals & Therapeutics Cancer Cachexia
Global Cancer Cachexia Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

In the year 2023, the Global Cancer Cachexia Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Pharmaceuticals & Therapeutics Cancer Drugs
Global Cancer Drugs Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

In the year 2023, the Global Cancer Drugs Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...